E. Dapretto

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo et al. · Journal of Clinical Oncology · 2010 · 301 citations · Full text

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial

Stefano Cascinu, Rossana Berardi, Roberto Labianca et al. · The Lancet Oncology · 2008 · 132 citations

Pancreatic Cancer, Phase Ii Trial, Gastrointestinal Oncology +6

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial

Roberto Labianca, Alberto F. Sobrero, L. Isa et al. · Annals of Oncology · 2010 · 108 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +6

A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach.

G Gardani, R Cerrone, C Biella et al. · PubMed · 2007 · 33 citations

Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer

Paolo Lissoni, A. Bignami, L. Frontini et al. · The International Journal of Biological Markers · 2005 · 16 citations